- PT Ratio = Patient PT ÷ PT Control.
- INR (estimated) = (PT Ratio)ISI when INR is not entered.
- Each test is compared against a reference interval to flag low, normal, or high.
- Severity is derived from abnormal counts and critical thresholds (educational flagging).
- Enter available results for PT, INR (optional), aPTT, fibrinogen, platelets, thrombin time, and D-dimer.
- Adjust PT control and ISI if your laboratory reports them.
- Click Calculate to view flagged ranges and derived values.
- Use the notes as prompts for clinical correlation, not as a diagnosis.
- Download a CSV of saved history or a PDF of the current result.
| Time | Label | PT | INR | aPTT | Fibrinogen | Platelets | Severity |
|---|---|---|---|---|---|---|---|
| No saved calculations yet. | |||||||
| Example | PT | PTc | ISI | PT Ratio | INR | aPTT | Fibrinogen | Platelets | TT | D-dimer | Severity |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample A | 12.4 | 12.0 | 1.0 | 1.03 | 1.0 | 29 | 310 | 240 | 16 | 0.3 | Normal |
| Sample B | 18.2 | 12.0 | 1.1 | 1.52 | 1.6 | 33 | 190 | 140 | 18 | 0.8 | Mild |
| Sample C | 24.5 | 12.0 | 1.2 | 2.04 | 2.2 | 68 | 90 | 42 | 28 | 6.2 | Critical |
Clinical value of a structured coagulation snapshot
Coagulation panels help teams detect bleeding and thrombosis risk patterns using a small set of measurable endpoints. This tool consolidates PT, INR, aPTT, fibrinogen, platelet count, thrombin time, and D‑dimer into one interpretation view. It compares each input against common adult reference intervals and highlights low, normal, or high flags to reduce manual scanning errors. In adult labs, PT often sits near 11–13.5 seconds and aPTT near 25–35 seconds, while fibrinogen is commonly 200–400 mg/dL and platelets 150–450 x10^9/L. These intervals vary with method, age, anticoagulants, and sample handling, so the ranges should be treated as configurable clinical context rather than universal truth.
Derived metrics that reduce calculation drift
Two derived metrics are emphasized for consistency. PT Ratio is calculated as patient PT divided by PT control. When INR is not provided, an estimated INR is produced using (PT Ratio)ISI. Documenting PT control and ISI prevents “hidden assumptions” that can shift INR meaning across analyzers, reagents, and institutions.
Interpretation cues across pathways
Patterns across tests can guide focused follow‑up. Isolated PT prolongation may align with extrinsic pathway effects, while isolated aPTT prolongation suggests intrinsic pathway involvement. When both PT and aPTT are prolonged, broad factor deficiency or multiple concurrent drivers become more plausible. Thrombin time adds context when heparin exposure, dysfibrinogenemia, or direct thrombin inhibitors are considerations.
Hemostatic strength and fibrinolysis markers
Fibrinogen and platelets contribute to clot strength, so low values can correlate with impaired hemostasis, especially during high‑risk procedures. D‑dimer is a fibrin degradation marker; elevated results are sensitive but not specific and can rise with infection, trauma, pregnancy, or postoperative states. The tool flags results but encourages clinical correlation rather than standalone conclusions.
Workflow, documentation, and audit readiness
For operational use, the calculator stores up to 20 recent entries in the current session, enabling quick comparison during rounds or handoffs. CSV export supports spreadsheet review and quality audits, while PDF export provides a clean attachment for case notes or peer review packets. Always verify patient identifiers and use your laboratory’s ranges for final reporting. Severity labeling is based on abnormal counts plus thresholds such as INR ≥4, platelets <50, fibrinogen <100, or times. This prioritizes attention but does not replace escalation policies. When results conflict with symptoms, repeat sampling and pre‑analytical checks help.
FAQs
1) Should I enter INR or let the tool estimate it?
If your lab reports INR, enter it for interpretation. If not, provide PT, PT control, and ISI to estimate INR consistently. Estimation is educational and may differ from instrument-calculated INR.
2) Why does PT control matter for PT Ratio and INR?
PT control is the normal reference clotting time for the reagent and analyzer. Changing PT control changes PT Ratio and estimated INR, so recording it improves comparability between sites and across reagent lots.
3) Can abnormal flags diagnose a disorder?
No. Flags indicate values outside reference intervals, not diagnoses. Pre-analytical issues, anticoagulants, liver function, inflammation, and dilutional effects can influence results. Use clinical assessment and confirmatory testing when needed.
4) What does an elevated D-dimer mean here?
It signals increased fibrin turnover and may support further evaluation when pretest probability is appropriate. D-dimer is non-specific and can rise with infection, trauma, pregnancy, surgery, and malignancy.
5) How is the severity label determined?
Severity is a prioritization cue based on abnormal result counts plus threshold flags like very high INR or very low platelets/fibrinogen. It helps triage review but does not replace local protocols or clinician judgment.
6) Is my data saved permanently?
No. The tool stores up to 20 entries in the current session only. Closing the session or clearing history removes them. Avoid entering identifiable information unless you follow your organization’s privacy rules.